Series A funding round for Checkmate Pharmaceuticals raising $20M in August 2015
Series A funding round for Checkmate Pharmaceuticals raising $20M in August 2015
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Jason Wang | |
| Angel | Jon Brelig | |
| Angel | Carol Gallagher | |
| Angel | James Park | |
| Angel | Ralph Gootee | |
| Angel | Manik Gupta |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$176M
Top Valuation
-
Checkmate Pharmaceuticals raised $20M in a Series A round.
The round was announced on 08/01/15.
The round was led by Michael Powell.